Gainers
- Cerenome (NASDAQ:CNSY) shares rose 39.5% to $1.07 during Friday's regular session. The market value of their outstanding shares is at $5.8 million. As per the press release, Q3 earnings came out today.
- SBC Medical Group Holding (NASDAQ:SBC) stock increased by 30.33% to $6.96. The market value of their outstanding shares is at $549.2 million. The company's, Q3 earnings came out today.
- Akanda (NASDAQ:AKAN) shares moved upwards by 25.08% to $0.84. The market value of their outstanding shares is at $1.7 million.
- VolitionRX (AMEX:VNRX) shares moved upwards by 24.71% to $0.23. The company's market cap stands at $5.5 million. As per the press release, Q3 earnings came out yesterday.
- LifeMD (NASDAQ:LFMD) shares moved upwards by 22.35% to $2.02. The company's market cap stands at $79.8 million. The company's, Q3 earnings came out yesterday.
- Codexis (NASDAQ:CDXS) shares increased by 20.55% to $1.16. The company's market cap stands at $104.9 million. As per the news, the Q3 earnings report came out yesterday.
Losers
- NeuroPace (NASDAQ:NPCE) shares declined by 50.5% to $5.95 during Friday's regular session. The market value of their outstanding shares is at $412.5 million. As per the press release, Q3 earnings came out yesterday.
- Oragenics (AMEX:OGEN) shares decreased by 46.51% to $0.19. The company's market cap stands at $1.5 million. As per the news, the Q3 earnings report came out yesterday.
- Owlet (NYSE:OWLT) stock decreased by 31.82% to $3.15. The market value of their outstanding shares is at $135.0 million. As per the news, the Q3 earnings report came out today.
- Lifeward (NASDAQ:LFWD) stock decreased by 29.73% to $4.02. The company's market cap stands at $16.1 million. As per the news, the Q3 earnings report came out today.
- GridAI Technologies (NASDAQ:GRDX) shares declined by 28.6% to $3.87. The company's market cap stands at $48.1 million.
- Lakewood-Amedex (NASDAQ:LABT) stock declined by 27.9% to $0.26. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


